A groundbreaking, first-of-its-kind advancement marks a new era in reverse shoulder arthroplasty, culminating in eight years of US clinical investigation and regulatory development ADDISON, Texas, Nov. 5, 2026 /PRNewswire/ -- FX Shoulder Solutions, Inc. (FX), a global innovator dedicated exclusively to shoulder arthroplasty, announces a historic and revolutionary breakthrough in shoulder replacement technology with the FDA 510(k) clearance of Easytech Reversed(R) - the first-and-only FDA-cleared stemless reverse shoulder arthroplasty system in the United States and a game-changer in how surgeons can care for their patients.

This landmark achievement introduces an entirely new category of reverse shoulder replacement technology to the US market, challenging traditional approaches to humeral fixation and potentially transforming the surgical options available to orthopedic surgeons and their patients.

With more than a decade of international clinical experience with Easytech(R) technology, FX brings an established stemless fixation philosophy to the world's largest shoulder arthroplasty market.